Feldmeier H, Schuster A. Mini review: hookworm-related cutaneous larva migrans. Eur J Clin Microbiol Infect Dis. 2012;31:915-918.
Tremblay A, MacLean JD, Gyorkos T, et al. Outbreak of cutaneous larva migrans in a group of travellers. Trop Med Int Health. 2000;5:330-334.
Davies HD, Sakuls P, Keystone JS. Creeping eruption. A review of clinical presentation and management of 60 cases presenting to a tropical disease unit. Arch Dermatol. 1993;129:588-591.
Hochedez P, Caumes E. Hookworm-related cutaneous larva migrans. J Travel Med. 2007;14:326-333.
Heukelbach J, Feldmeier H. Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans. Lancet Infect Dis. 2008;8:302-309.
Veraldi S, Persico MC, Francia C, et al. Follicular cutaneous larva migrans: a report of three cases and review of the literature. Int J Dermatol. 2013;52:327-330.
Caumes E, Carriere J, Datry A, et al. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg. 1993;49:641-644.
1. Feldmeier H, Schuster A. Mini review: hookworm-related cutaneous larva migrans. Eur J Clin Microbiol Infect Dis. 2012;31:915-918.
2. Tremblay A, MacLean JD, Gyorkos T, et al. Outbreak of cutaneous larva migrans in a group of travellers. Trop Med Int Health. 2000;5:330-334.
3. Davies HD, Sakuls P, Keystone JS. Creeping eruption. A review of clinical presentation and management of 60 cases presenting to a tropical disease unit. Arch Dermatol. 1993;129:588-591.
4. Caumes E, Ly F, Bricaire F. Cutaneous larva migrans with folliculitis: report of seven cases and review of the literature. Br J Dermatol. 2002;146:314-316.
5. Gutierrez de la Solana Dumas J, Alvarez Mesa M, Manzur Katrib J. An outbreak of cutaneous larva migrans [in Spanish]. Rev Cubana Med Trop. 1983;35:303-316.
6. Heukelbach J, Wilcke T, Feldmeier H, et al. Cutaneous larva migrans (creeping eruption) in an urban slum in Brazil. Int J Dermatol. 2004;43:511-515.
7. Kannathasan S, Murugananthan A, Rajeshkannan N, et al. Cutaneous larva migrans among devotees of the Nallur temple in Jaffna, Sri Lanka. PLoS One. 2012;7:e30516.
8. Schuster A, Lesshafft H, Talhari S, et al. Life quality impairment caused by hookworm-related cutaneous larva migrans in resource-poor communities in Manaus, Brazil. PLoS Negl Trop Dis. 2011;5:e1355.
9. Reichert F, Pilger D, Schuster A, et al. Prevalence and risk factors of hookworm-related cutaneous larva migrans (HrCLM) in a resource-poor community in Manaus, Brazil. PLoS Negl Trop Dis. 2016;10:e0004514.
10. Jelinek T, Maiwald H, Nothdurft HD, et al. Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis. 1994;19:1062-1066.
11. Lee VJ, Ong A, Lee NG, et al. Hookworm infections in Singaporean soldiers after jungle training in Brunei Darussalam. Trans R Soc Trop Med Hyg 2007;101:1214-1218.
12. Gautret P, Cramer JP, Field V, et al. Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010. Euro Surveill. 2012;17:pii:20205.
13. Stevens MS, Geduld J, Libman M, et al. Dermatoses among returned Canadian travellers and immigrants: surveillance report based on CanTravNet data, 2009-2012. CMAJ Open. 2015;3:E119-E126.
14. Simon MW, Simon NP. Cutaneous larva migrans. Pediatr Emerg Care. 2003;19:350-352.
15. Boland TW, Agger WA. Cutaneous larva migrans; recent experience in the La Crossa area. Wis Med J. 1980;79:32-34.
16. O'Quinn JC, Dushin R. Cutaneous larva migrans: case report with current recommendations for treatment. J Am Podiatr Med Assoc. 2005;95:291-294.
17. Heukelbach J, Wilcke T, Meier A, et al. A longitudinal study on cutaneous larva migrans in an impoverished Brazilian township. Travel Med Infect Dis. 2003;1:213-218.
18. Hochedez P, Caumes E. Hookworm-related cutaneous larva migrans. J Travel Med. 2007;14:326-333.
19. Heukelbach J, Feldmeier H. Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans. Lancet Infect Dis. 2008;8:302-309.
20. Blackwell V, Vega-Lopez F. Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller. Br J Dermatol. 2001;145:434-437.
21. Hotez PJ, Narasimhan S, Haggerty J, et al. Hyaluronidase from infective Ancylostoma hookworm larvae and its possible function as a virulence factor in tissue invasion and in cutaneous larva migrans. Infect Immun. 1992;60:1018-1023.
22. Edelglass JW, Douglass MC, Stiefler R, et al. Cutaneous larva migrans in northern climates. A souvenir of your dream vacation. J Am Acad Dermatol. 1982;7:353-358.
23. Kollaritsch H, Jeschko E, Wiedermann G. Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results of an open pilot trial in travellers returning from the tropics. Trans R Soc Trop Med Hyg. 1993;87:689.
24. Boggild AK, Yohanna S, Keystone JS, et al. Prospective analysis of parasitic infections in Canadian travelers and immigrants. J Travel Med. 2006;13:138-144.
25. Heukelbach J, Mencke N, Feldmeier H. Cutaneous larva migrans and tungiasis: the challenge to control zoonotic ectoparasitoses associated with poverty. Trop Med Int Health. 2002;7:907-910.
26. Kannathasan S, Murugananthan A, Rajeshkannan N, et al. A simple intervention to prevent cutaneous larva migrans among devotees of the Nallur Temple in Jaffna, Sri Lanka. PLoS One. 2013;8:e61816.
27. Heukelbach J, Gomide M, Araújo F Jr, et al. Cutaneous larva migrans and tungiasis in international travellers exiting Brazil: an airport survey. J Travel Med. 2007;14:374-380.
28. Bouchaud O, Houzé S, Schiemann R, et al. Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis. 2000;31:493-498. [Erratum in: Clin Infect Dis. 2001;32:523.]
29. Feldmeier H, Jackson A, Heukelbach J, et al. A study in a community in Brazil in which cutaneous larva migrans is endemic. Clin Infect Dis. 2006;43:e13-e18.
30. Veraldi S, Arancio L. Giant bullous cutaneous larva migrans. Clin Exp Dermatol. 2006;31:613-614.
31. Veraldi S, Persico MC, Francia C, et al. Follicular cutaneous larva migrans: a report of three cases and review of the literature. Int J Dermatol. 2013;52:327-330.
32. Shimogawara R, Hata N, Schuster A, et al. Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatment. Eur J Microbiol Immunol (Bp). 2013;3:258-266.
33. Veraldi S, Schianchi R, Carrera C. Epiluminescence microscopy in cutaneous larva migrans. Acta Derm Venereol. 2000;80:233.
34. Le Joncour A, Lacour SA, Lecso G, et al. Molecular characterization of Ancylostoma braziliense larvae in a patient with hookworm-related cutaneous larva migrans. Am J Trop Med Hyg. 2012;86:843-845.
35. von Kuster LC, Genta RM. Cutaneous manifestations of strongyloidiasis. Arch Dermatol. 1988;124:1826-1830.
36. Mukherjee A, Ahmed NH, Samantaray JC, et al. A rare case of cutaneous larva migrans due to Gnathostoma sp. Indian J Med Microbiol. 2012;30:356-358.
37. Vanhaecke C, Perignon A, Monsel G, et al. Aetiologies of creeping eruption: 78 cases. Br J Dermatol. 2014;170:1166-1169.
38. Xuan LT, Hung NT, Waikagul J. Cutaneous fascioliasis: a case report in Vietnam. Am J Trop Med Hyg. 2005;72:508-509.
39. Makino T, Mori N, Sugiyama H, et al. Creeping eruption due to Spirurina type X larva. Lancet. 2014;384:2082.
40. Hurwitz S, Paller AS, Mancini J. Hurwitz clinical pediatric dermatology: a textbook of skin disorders of childhood and adolescence. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2006.
41. Caumes E. It's time to distinguish the sign 'creeping eruption' from the syndrome 'cutaneous larva migrans'. Dermatology. 2006;213:179-181.
42. Burnett JW, Nguyen TV. Phytophotodermatitis: differentiation from jellyfish stings. Australas J Dermatol. 1989;30:101-102.
43. Vanhaecke C, Perignon A, Monsel G, et al. The efficacy of single dose ivermectin in the treatment of hookworm related cutaneous larva migrans varies depending on the clinical presentation. J Eur Acad Dermatol Venereol. 2014;28:655-657.
44. Caumes E, Carriere J, Guermonprez G, et al. Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis. 1995;20:542-548.
45. Van den Enden E, Stevens A, Van Gompel A. Treatment of cutaneous larva migrans. N Engl J Med. 1998;339:1246-1247.
46. Caumes E, Carriere J, Datry A, et al. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg. 1993;49:641-644.
47. Jones SK, Reynolds NJ, Oliwiecki S, et al. Oral albendazole for the treatment of cutaneous larva migrans. Br J Dermatol. 1990;122:99-101.
48. Stone OJ, Mullins JF. Thiabendazole effectiveness in creeping eruption. Arch Dermatol. 1965;91:427-429.
49. Del Giudice P, Desalvador F, Bernard E, et al. Loeffler's syndrome and cutaneous larva migrans: a rare association. Br J Dermatol. 2002;147:386-388.
50. Gandullia E, Lignana E, Rabagliati AM, et al. Visceral larva migrans caused by Ancylostoma caninum [in Italian]. Minerva Pediatr. 1981;33:917-923.
51. Vaughan TK, English JC 3rd. Cutaneous larva migrans complicated by erythema multiforme. Cutis. 1998;62:33-35.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台